Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Mesothelioma, Malignant × talazoparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Breast Neoplasms 13 Triple Negative Breast Neoplasms 7 Prostatic Neoplasms 7 Neoplasms 6 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Endometrial Neoplasms 2 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Prostatic Diseases 1 Prostate Cancer Metastatic 1 Premenopausal HR+/HER2- Metastatic Breast Cancer 1 Pheochromocytoma 1 Pathologic Complete Response 1 Paraganglioma 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Hemangiosarcoma 1 Glioma 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Extensive Stage Lung Small Cell Carcinoma 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

Cisplatin 28 Pemetrexed 22 Gemcitabine 10 Nivolumab 9 Carboplatin 9 pembrolizumab 8 tremelimumab 5 durvalumab 5 atezolizumab 5 Radiotherapy 5 Doxorubicin 4 Chemotherapy, Adjuvant 4 Vinorelbine 3 Ipilimumab 3 Bortezomib 3 Bevacizumab 3 tumor necrosis factor-alpha, CNGRC fusion protein, human 2 sodium thiosulfate 2 sargramostim 2 niraparib 2 nintedanib 2 liposomal doxorubicin 2 lenvatinib 2 defactinib 2 cemiplimab 2 cediranib 2 amatuximab 2 Trabectedin 2 Neoadjuvant Therapy 2 Mitomycin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04462809 2020-07-09

TALAMESO

Hospices Civils de Lyon

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡